Literature DB >> 16751104

p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation.

Irene E Zohn1, Yingqiu Li, Edward Y Skolnik, Kathryn V Anderson, Jiahuai Han, Lee Niswander.   

Abstract

During vertebrate gastrulation, an epithelial to mesenchymal transition (EMT) is necessary for migration of mesoderm from the primitive streak. We demonstrate that p38 MAP kinase and a p38-interacting protein (p38IP) are critically required for downregulation of E-cadherin during gastrulation. In an ENU-mutagenesis screen we identified the droopy eye (drey) mutation, which affects splicing of p38IP. p38IP(drey) mutant embryos display incompletely penetrant defects in neural tube closure, eye development, and gastrulation. A stronger allele (p38IP(RRK)) exhibits gastrulation defects in which mesoderm migration is defective due to deficiency in E-cadherin protein downregulation in the primitive streak. We show that p38IP binds directly to p38 and is required for p38 activation in vivo. Moreover, both p38 and p38IP are required for E-cadherin downregulation during gastrulation. Finally, p38 regulates E-cadherin protein expression downstream from NCK-interacting kinase (NIK) and independently of the regulation of transcription by Fibroblast Growth Factor (Fgf) signaling and Snail.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751104     DOI: 10.1016/j.cell.2006.03.048

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  108 in total

Review 1.  ATAC-king the complexity of SAGA during evolution.

Authors:  Gianpiero Spedale; H Th Marc Timmers; W W M Pim Pijnappel
Journal:  Genes Dev       Date:  2012-03-15       Impact factor: 11.361

2.  An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition.

Authors:  Claude C Warzecha; Peng Jiang; Karine Amirikian; Kimberly A Dittmar; Hezhe Lu; Shihao Shen; Wei Guo; Yi Xing; Russ P Carstens
Journal:  EMBO J       Date:  2010-08-13       Impact factor: 11.598

3.  The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Authors:  Lei-Ping Wang; Jun Cao; Jian Zhang; Bi-Yun Wang; Xi-Chun Hu; Zhi-Min Shao; Zhong-Hua Wang; Zhou-Luo Ou
Journal:  Med Oncol       Date:  2015-10-20       Impact factor: 3.064

4.  BMK1 kinase suppresses epithelial-mesenchymal transition through the Akt/GSK3β signaling pathway.

Authors:  Runqiang Chen; Qingkai Yang; Jiing-Dwan Lee
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

5.  Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.

Authors:  David D Tran; Callie Ann S Corsa; Hirak Biswas; Rebecca L Aft; Gregory D Longmore
Journal:  Mol Cancer Res       Date:  2011-10-17       Impact factor: 5.852

6.  Regulation of Xenopus gastrulation by ErbB signaling.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Dev Biol       Date:  2006-11-10       Impact factor: 3.582

7.  E-cadherin regulates the behavior and fate of epithelial stem cells and their progeny in the mouse incisor.

Authors:  Chun-Ying Li; Wanghee Cha; Hans-Ulrich Luder; Roch-Philippe Charles; Martin McMahon; Thimios A Mitsiadis; Ophir D Klein
Journal:  Dev Biol       Date:  2012-04-18       Impact factor: 3.582

8.  The Snail repressor is required for PMC ingression in the sea urchin embryo.

Authors:  Shu-Yu Wu; David R McClay
Journal:  Development       Date:  2007-02-07       Impact factor: 6.868

Review 9.  Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

Authors:  Hervé Acloque; Meghan S Adams; Katherine Fishwick; Marianne Bronner-Fraser; M Angela Nieto
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

10.  EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis.

Authors:  Heather M Moore; Maria E Gonzalez; Kathy A Toy; Ashley Cimino-Mathews; Pedram Argani; Celina G Kleer
Journal:  Breast Cancer Res Treat       Date:  2013-03-29       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.